Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathy

Antonio Romero-Puche1, Francisco Marín, Josefa González-Carrillo

  • 1Servicio de Cardiología, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.

Insights

Myocardial fibrosis detected by cardiac magnetic resonance is linked to reduced exercise capacity in hypertrophic cardiomyopathy patients. This finding highlights fibrosis as a key indicator of functional limitation.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease.
  • Traditional markers of HCM are insufficient for predicting functional disability.
  • Gadolinium-enhanced cardiovascular magnetic resonance (CMR) can detect myocardial fibrosis.

Purpose of the Study:

  • To investigate the association between the extent of myocardial fibrosis, identified by CMR, and exercise capacity in HCM patients.
  • To determine if fibrosis is a predictor of functional limitation in HCM.

Main Methods:

  • 98 HCM patients underwent CMR, echocardiography, exercise testing, and Holter monitoring.
  • Myocardial fibrosis was quantified as the percentage of myocardium with late gadolinium enhancement on CMR.
  • Exercise capacity was measured in metabolic equivalent (MET) units.

Main Results:

  • Late gadolinium enhancement was present in 68.4% of patients.
  • Patients with fibrosis had significantly lower exercise capacity (8.04 METs vs. 10.41 METs, P=.003).
  • A significant inverse correlation was found between fibrosis percentage and exercise capacity (r=-0.21, P=.044).
  • N-terminal probrain natriuretic peptide (NT-proBNP) was the strongest predictor of exercise capacity.
  • Multivariate analysis identified age, atrial fibrillation history, NT-proBNP, and fibrosis as independent predictors of exercise capacity.

Conclusions:

  • Late gadolinium enhancement on CMR is independently associated with reduced exercise capacity in HCM.
  • Myocardial fibrosis is a significant imaging biomarker for functional impairment in HCM.
  • CMR-detected fibrosis provides valuable prognostic information in hypertrophic cardiomyopathy.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...